X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.120
-0.090 (-2.14%)
At close: Apr 28, 2026, 4:00 PM EDT
4.130
+0.010 (0.24%)
After-hours: Apr 28, 2026, 7:32 PM EDT
X4 Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for X4 Pharmaceuticals stock have an average target of 9.00, with a low estimate of 5.00 and a high estimate of 12. The average target predicts an increase of 118.45% from the current stock price of 4.12.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 9, 2026.
Analyst Ratings
The average analyst rating for X4 Pharmaceuticals stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 4 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +191.26% | Mar 9, 2026 |
| Stifel | Stifel | Strong Buy Maintains $7.5 → $10 | Strong Buy | Maintains | $7.5 → $10 | +142.72% | Dec 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3.5 → $5 | Strong Buy | Maintains | $3.5 → $5 | +21.36% | Nov 10, 2025 |
| Stifel | Stifel | Strong Buy Maintains $30 → $9 | Strong Buy | Maintains | $30 → $9 | +118.45% | Aug 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $3.5 | Strong Buy | Maintains | $7 → $3.5 | -15.05% | Aug 13, 2025 |
Financial Forecast
Revenue This Year
8.19M
from 35.11M
Decreased by -76.66%
Revenue Next Year
7.34M
from 8.19M
Decreased by -10.37%
EPS This Year
-0.89
from -1.87
EPS Next Year
-0.84
from -0.89
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 11.6M | 8.3M | |||
| Avg | 8.2M | 7.3M | |||
| Low | 6.2M | 6.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -67.1% | 1.2% | |||
| Avg | -76.7% | -10.4% | |||
| Low | -82.4% | -22.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.74 | -0.58 | |||
| Avg | -0.89 | -0.84 | |||
| Low | -1.02 | -0.95 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.